Journal of Clinical Investigation · 1997 · 137 citations · 47 references
MedicineEndocrinologyGeneticsCalcium HomeostasisHuman GeneticsMedical GeneticsDisorders Of Calcium MetabolismGenetic DisordersVitamin DVitamin D DeficiencyVitamin D DisordersVitamin D MetabolismCalcitriol DeficiencyCalcitriol TherapyGenetic Disorders Of Vitamin MetabolismMutationPersistent Müllerian Duct SyndromeVitamin D InsufficiencyVitamin D ReceptorsVitamin D Resistance
Mutations in the vitamin D receptor (VDR) result in target organ resistance to 1alpha,25-dihydroxyvitamin D [1,25(OH)2D3], the active form of vitamin D, and cause hereditary 1,25-dihydroxyvitamin D resistant rickets (HVDRR). We analyzed the VDR of a patient who exhibited three genetic diseases: HVDRR, congenital total lipodystrophy, and persistent mullerian duct syndrome. The patient was treated with extremely high dose calcitriol (12.5 microg/d) which normalized serum calcium and improved his rickets. Analysis of [3H]1,25(OH)2D3 binding in the patient's cultured fibroblasts showed normal abundance of VDR with only a slight decrease in binding affinity compared to normal fibroblasts when measured at 0 degrees C. The patient's fibroblasts demonstrated 1,25(OH)2D3-induction of 24-hydroxylase mRNA, but the effective dose was approximately fivefold higher than in control cells. Sequence analysis of the patient's VDR gene uncovered a single point mutation, H305Q. The recreated mutant VDR was transfected into COS-7 cells where it was 5 to 10-fold less responsive to 1,25(OH)2D3 in gene transactivation. The mutant VDR had an eightfold lower affinity for [3H]1,25(OH)2D3 than the normal VDR when measured at 24 degrees C. RFLP demonstrated that the patient was homozygous for the mutation while the parents were heterozygous. In conclusion, we describe a new ligand binding domain mutation in the VDR that causes HVDRR due to decreased affinity for 1,25(OH)2D3 which can be effectively treated with extremely high doses of hormone.
47
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
William Bourguet, Marc Ruff, Pierre Chambon et al. · Nature · 1995 · 1.2K citations
Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
Jean‐Paul Renaud, Natacha Rochel, Marc Ruff et al. · Nature · 1995 · 1.1K citations